Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...
February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...
Sanofi’s Earnings Call Balances Strong Growth With Manageable Risks ...
Researchers have used advanced microscopy and computational modeling to show how herpesvirus infection affects host-cell nucleus structure.
A new study analysis reveals 40% of global cancer cases are preventable by addressing 30 modifiable lifestyle risk factors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results